Drug Profile
Research programme: micelle nanoparticle therapeutics - NanoCarrier
Alternative Names: Docetaxel micelle; Medicelle®; protein micelle; Sensor linked micelle; siRNA micelleLatest Information Update: 28 Nov 2021
Price :
$50
*
At a glance
- Originator NanoCarrier
- Developer JCR Pharmaceuticals; NanoCarrier
- Class Antibodies; Boronic acids; Polymers; Proteins; Pyrazines; Small interfering RNA; Small molecules; Taxanes
- Mechanism of Action Apoptosis stimulants; Biological factor modulators; Immunomodulators; Mitosis inhibitors; Proteasome inhibitors; RNA interference; Tubulin modulators; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Brain disorders; Cancer; Haemophilia; Unspecified
Most Recent Events
- 28 Nov 2021 No recent reports of development identified for research development in Brain-disorders in Japan
- 04 Nov 2017 No recent reports of development identified for research development in Cancer in Japan (Parenteral)
- 04 Nov 2017 No recent reports of development identified for research development in Haemophilia in Japan (Parenteral)